Valiant Laboratories Limited has informed the Exchange about Submission of Letter of Offer for Rights Issue of Fully Paid-up Equity Shares.
VALIANTLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 11.0 pts less than Nifty Microcap 250, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Valiant Laboratories Limited has submitted the Letter of Offer for a Rights Issue of up to 1,08,62,500 fully paid-up equity shares at a price of ₹75 per share, including a premium of ₹65 over the face value of ₹10. The total issue size aggregates to ₹8,146.88 Lakhs (assuming full subscription). Eligible shareholders can subscribe in the ratio of 1 rights share for every 4 equity shares held as on the record date of July 19, 2025. The issue opens on July 28, 2025 and closes on August 8, 2025, with listing expected by August 13, 2025. The company has received in-principle approvals from both BSE and NSE for listing the rights shares.
Existing shareholders need to evaluate whether to subscribe to their rights entitlements by August 8, 2025, to maintain their proportional ownership in the company. The rights shares will dilute existing shareholdings for those who choose not to participate, while offering new shares at the set issue price.